Ventana Medical Systems, Inc. C3d 760-4522

Description
Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. C3d deposition in the renal transplant PTCs (peritubular capillaries) is indicative of AR (acute rejection) with subsequent high probability of graft loss. Anti-C3d, combined with anti-C4d, can be utilized as a tool for diagnosis of AR and warrant prompt and aggressive anti-rejection treatment.
Description
Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. C3d deposition in the renal transplant PTCs (peritubular capillaries) is indicative of AR (acute rejection) with subsequent high probability of graft loss. Anti-C3d, combined with anti-C4d, can be utilized as a tool for diagnosis of AR and warrant prompt and aggressive anti-rejection treatment.

Suppliers

Company
Product
Description
Supplier Links
Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. C3d deposition in the renal transplant PTCs (peritubular capillaries) is indicative of AR (acute rejection) with subsequent high probability of graft loss. Anti-C3d, combined with anti-C4d, can be utilized as a tool for diagnosis of AR and warrant prompt and aggressive anti-rejection treatment.

Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. C3d deposition in the renal transplant PTCs (peritubular capillaries) is indicative of AR (acute rejection) with subsequent high probability of graft loss. Anti-C3d, combined with anti-C4d, can be utilized as a tool for diagnosis of AR and warrant prompt and aggressive anti-rejection treatment.

Supplier's Site

Technical Specifications

  Ventana Medical Systems, Inc.
Product Category Organic Chemicals
Product Number 760-4522
Product Name C3d
Unlock Full Specs
to access all available technical data

Similar Products

Intermediates and Ingredients for Pharmaceuticals and Agrochemical Compounds -  - AGC Chemicals Americas, Inc.
Specs
Chemical Family All Halogenated
Chemical Name Trifluoroacetic Acid, Trifluoroacetic Anhydride, Ethyl Trifluoroacetate, Sodium Trifluoroacetate, 2,3,4-Trifluoro aniline, Trifluoroacetamide, & More
CAS Number 76-05-1, 407-25-0, 383-63-1, 2923-18-4, 3862-73-5, 354-38-1, 148043-73-6, 30071-93-3, 677-69-0, 122665-97-8, 118612-00-3, 136040-19-2, and More
View Details
DMI 1,3 Dimethyl-2-Imidazolidinone -  - Mitsui Chemicals America, Inc.
Mitsui Chemicals America, Inc.
Specs
Trigger Solvent
Chemical Name DMI 1,3 Dimethyl-2-Imidazolidinone
State of Matter Liquid / Solution
View Details
Acetic Acid -  - Esprix Technologies
Esprix Technologies
Specs
Trigger Acid
Chemical Family Acetic Acid
Chemical Name Acetic Acid
View Details
CONFIRM CD20 - 760-2531 - Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc.
View Details